Skip to content

Biote Corp. BTMD Derivative Liability, Noncurrent

Derivative Liability, Noncurrent at other companies

Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR

Other financials

Income statement

See full
Revenue$44.9M-8.3%
Gross profit$31.0M-14.9%
Operating income$3.2M-67.3%
Net income$2.3M-83.4%
EPS (diluted)$0.06-83.8%

Balance sheet

See full
Cash & equivalents$5.3M-87.2%
Total debt$103.4M-5.5%
Total equity-$56.1M+37.7%
Total assets$89.0M-27.8%

Cash flow

See full
Operating cash flow$3.9M-39.7%
CapEx$362.0K-77.8%
Free cash flow$3.5M-26.8%

Valuation

See full
Market cap$57.33M-51.2%
Enterprise value$155.43M-26.5%
P/E3.7×-0.1×
P/S0.3×-0.3×

Profitability

See full
Gross margin70.1%-1.2pp
Operating margin15.4%-0.1pp
Net margin8.3%-2.3pp
FCF margin15.3%-3.2pp

Returns & leverage

See full
Return on equity-21.4%
Debt / equity9.1×
Current ratio1.3×-0.1×

Where this comes from

Reported directly by Biote Corp. in its filing.

Tagged under the XBRL concept us-gaap:DerivativeLiabilitiesNoncurrent.

The official record: Biote Corp.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biote Corp.'s derivative liability, noncurrent.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biote Corp.'s derivative liability, noncurrent?
Biote Corp. (BTMD) reported derivative liability, noncurrent of $1.96M in Q1 2026.
How has Biote Corp.'s derivative liability, noncurrent changed year-over-year?
Biote Corp.'s derivative liability, noncurrent decreased by 69.6% year-over-year, from $6.45M to $1.96M.
What is the long-term trend for Biote Corp.'s derivative liability, noncurrent?
Over 3 years (2022 to 2025), Biote Corp.'s derivative liability, noncurrent has grown at a -49.6% compound annual growth rate (CAGR), from $32.11M to $4.11M.